COMMUNIQUÉS West-GlobeNewswire

CorVel Named 2026 PropertyCasualty360 Insurance Luminaries Winner for Excellence in Claims Management
08/07/2026
FORT WORTH, Texas, July 08, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, today announced it has been named a 2026 PropertyCasualty360 Insurance Luminaries [...]
Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care
08/07/2026
The board features stroke experts from the US, UK, Canada, Spain, Nigeria and Australia CAMBRIDGE, United Kingdom, July 08, 2026 (GLOBE NEWSWIRE) -- A Cambridge-founded medtech company developing rapid blood tests for [...]
Ontario’s Lung Cancer Screening Program Ranks Among World’s Best, but Half of Patients Are Still Diagnosed at Advanced Stages, New Report Finds
08/07/2026
Lung Health Foundation’s landmark baseline report shows a system with exceptional foundations – and critical blind spots in equity, patient experience, and access that could determine whether Ontario meets the Pan- [...]
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging
08/07/2026
Publication demonstrates how complementary IVUS and OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- [...]
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
08/07/2026
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today [...]
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08/07/2026
FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimod Company unveils NEPTUNE ( N europathic E [...]
Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases
08/07/2026
Free platform empowers patients and families with information on 53 diseases, 125 genes, active clinical trials, treatment pipelines, and support resources GILBERT, Ariz., July 08, 2026 (GLOBE NEWSWIRE) -- Today, as co- [...]
Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment
08/07/2026
80% of SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the Investigator-Sponsored Trial (IST) conducted by Memorial Sloan Kettering Cancer Center [...]
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
08/07/2026
Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine platform designed to [...]
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
08/07/2026
LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION ® , a tumor-activated oncology [...]
On World Obesity Day, WONDERLAB Releases the Targeted Microbiota Weight Management White Paper
08/07/2026
SHENZHEN, China, July 08, 2026 (GLOBE NEWSWIRE) -- WONDERLAB, a leading Chinese probiotics company ranked No.1 in probiotic sales in China,¹ has published the Targeted Microbiota Weight Management White Paper, a strain- [...]
Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité
08/07/2026
Novo Nordisk s’apprête à mener une évaluation interne non exclusive des implants à base de sémaglutide élaborés par Vivani ALAMEDA, Californie, 08 juill. 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq : VANI) (« [...]
Dumbo Health Launches SleepLongevityAge, Bringing Clinical Care to the World’s Most Overlooked Health Metric
08/07/2026
Introducing Sleep Longevity: a new category of care that turns the world’s most overlooked health metric into action. Sleep better. Live longer. Miami, Florida, July 08, 2026 (GLOBE NEWSWIRE) -- Millions of people wake [...]
Trimoryn Supplement Facts Analysis: Latest Safety Report Issued to Consumers About Ingredients' Effectiveness & Side Effects Risk
08/07/2026
Trimoryn issues a 2026 supplement facts and consumer safety update covering its weight management support formula, ingredient amounts, suggested use, side effects risk considerations, customer support details, and 60- [...]
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
08/07/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
08/07/2026
Serial entrepreneur Crosby has brought numerous implantable medical devices through CE marking, U.S. FDA approval and commercial launch Joins as Tensive approaches pivotal clinical and regulatory milestones for its [...]
AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins
08/07/2026
NEURIED, Germany and NESLE, France, July 08, 2026 (GLOBE NEWSWIRE) -- AMSilk, a global leader in biotech produced silk materials, today announced a significant expansion of its partnership with Ajinomoto Foods Europe ( [...]
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
08/07/2026
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics [...]
Resmed Announces Agreement to Sell MatrixCare Business
07/07/2026
Sharpens Resmed’s focus on high-growth sleep and connected care markets SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and [...]

Pages